CytoSorbents Medical Inc. SBIR Phase II Award, September 2020
A SBIR Phase II contract was awarded to CytoSorbents Medical Inc. in September, 2020 for $1,098,589.0 USD from the U.S. Department of Defense and Defense Health Agency.
Currently, there are no issues on this topic.
Find more entities like CytoSorbents Medical Inc. SBIR Phase II Award, September 2020
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.